The FDA approved carbachol/brimonidine tartrate ophthalmic solution (Yuvezzi) for adults with presbyopia, making it the first ...
The FDA approved Yuvezzi, an eye drop for the treatment of presbyopia, with broad U.S. availability expected in the second quarter, according to a press release from Tenpoint Therapeutics. Yuvezzi ...
The FDA cleared an investigational new drug application to advance NOV05 in a phase 2 clinical trial in noninfectious ...
Injectable dermal products have become some of the most sought-after cosmetic treatments. But behind every injection lies a complex combination of materials that determines how these products behave ...
Group results In 2025, Roche achieved sales growth of 7% (2% in CHF) to CHF 61.5 billion due to strong demand for pharmaceutical products and diagnostic solutions. The appreciation of the Swiss franc ...
Group sales grew by 7%1 at constant exchange rates (CER; 2% in CHF), driven by strong demand for medicines and diagnostic solutions.Sales in the fourth quarter increased by 8%, reflecting the positive ...
Thank you to everyone who entered our 11th Annual Holiday Tech Giveaway! The response this year has been incredible, and we’re grateful for your continued support of Android Headlines. Winner ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results